Ovo Labs - About the company
Ovo Labs is a seed company based in Munich (Germany), founded in 2025 by Agata Zielinska, Oleksandr Sasha Yagensky and Melina Schuh. It operates as a Developer of therapeutics designed to improve the quality of human eggs. Ovo Labs has raised $5.32M in funding from LocalGlobe and Creator Fund. The company has 65 active competitors, including 21 funded and 8 that have exited. Its top competitors include companies like Rejoni, Gameto and Sprout Pharmaceuticals.
Company Details
Developer of therapeutics designed to improve the quality of human eggs. The therapies aim of extending womens reproductive timelines by addressing age-related deterioration in oocyte quality, enhancing fertility and increasing the chances of successful in-vitro fertilization.
Key Metrics
Founded Year
2025
Location
Munich, Germany
Stage
Seed
Total Funding
$5.32M in 1 round
Latest Funding Round
Investors
Ranked
21st among 65 active competitors
Employee Count
11 as on Jun 30, 2026
Similar Companies
Legal entities associated with Ovo Labs
Ovo Labs is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Ovo Labs Gmbh CIN: HRB300226 , Germany, Active | Feb 24, 2025 | - | - |
Sign up to download Ovo Labs' company profile
Ovo Labs's funding and investors
Ovo Labs has raised a total funding of $5.32M over 1 round. Its latest funding round was a Seed round on Apr 24, 2025 for $*****. 4 investors participated in its latest round. Ovo Labs has 4 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Ovo Labs:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 24, 2025 | 4055126 | Seed | 9939497 | 2307323 | 9181083 | 8728952 |
View details of Ovo Labs's funding rounds and investors
Ovo Labs' founders and board of directors
Founder? Claim ProfileThe founders of Ovo Labs are Agata Zielinska, Oleksandr Sasha Yagensky and Melina Schuh. Oleksandr Sasha Yagensky and Agata Zielinska are the CEOs of Ovo Labs.
Here are the details of Ovo Labs' key team members:
- Agata Zielinska: Co-Founder & Co-CEO of Ovo Labs. They serve on the board of 1 company.Contact Info: 1 email address
- Oleksandr Sasha Yagensky: Co-Founder & Co-CEO of Ovo Labs. They serve on the board of 1 company.Contact Info: 1 email address
- Melina Schuh: Co-Founder & Chairwoman of Ovo Labs. Contact Info: 1 email address
Ovo Labs' Board of Directors
Ovo Labs's board has 2 active members. Agata Zielinska and Oleksandr Sasha Yagensky are part of team.Here is the list of Ovo Labs' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 1y 5m | |
Team | - | Current | 1y 5m |
View details of Ovo Labs's Founder profiles and Board Members
Ovo Labs' employee count trend
Ovo Labs has 11 employees as of Jun 26. Here is Ovo Labs's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Ovo Labs's Competitors and alternates
Top competitors of Ovo Labs include Rejoni, Gameto and Sprout Pharmaceuticals. Here is the list of Top 10 competitors of Ovo Labs, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Rejoni 2020, Bedford (United States), Series B | Developer of therapeutics to treat women health conditions | $66.3M | 61/100 | |
2nd | Gameto 2020, United States, Series C | Developer of therapeutics for the treatment of fertility and menopause | $127M | 58/100 | |
3rd | Sprout Pharmaceuticals 2011, Raleigh (United States), Acquired | Developer of drugs for hypoactive sexual desire disorder in women | $185M | 57/100 | |
4th | Hope Medicine 2018, Shanghai (China), Series B | Developer of monoclonal antibodies for the treatment of multiple diseases | $56M | 56/100 | |
5th | OvaScience 2011, Waltham (United States), Public | Developer of new fertility treatments for women | $76.9M | 55/100 | |
6th | Manufacturer of women care medicines | $19M | 52/100 | ||
7th | RenewalBio 2022, Rehovot (Israel), Seed | Developer of a synthetic embryo and stem-cell therapeutic platform | - | 50/100 | |
8th | Developer of antibodies for the treatment of infertility | $8.53M | 50/100 | ||
9th | Dioseve Inc 2021, Bunkyo (Japan), Series A | Developer of iPS cell-derived egg production technology for infertility treatment | $16.2M | 46/100 | |
10th | Granata Bio 2018, Duxbury (United States), Series A | Developer of therapeutics for women's health and infertility | $29M | 46/100 | |
21st | Developer of therapeutics designed to improve the quality of human eggs | $5.32M | 41/100 |
Looking for more details on Ovo Labs's competitors? Click here to see the top ones
Ovo Labs's Investments and acquisitions
Ovo Labs has made no investments or acquisitions yet.
Reports related to Ovo Labs
Here is the latest report on Ovo Labs's sector:
News related to Ovo Labs
•
Ovo Labs Secures €4.7 Million Seed FundingMunich•Apr 30, 2025•Ovo Labs, Creator Fund, Phoenix Court, Blue Wire Capital and 1 other
Are you a Founder ?
FAQs about Ovo Labs
Explore our recently published companies
- OYD - Seoul based, 2025 founded, Unfunded company
- Backlane - Unfunded company
- MeasureU - Washington based, 2013 founded, Unfunded company
- Fogeris - France based, 2002 founded, Unfunded company
- Foraged Words - Charleston based, 2020 founded, Unfunded company
- eXpotencial - Madrid based, Unfunded company
